Dr. Wendy Sanhai, is a specialist leader with Deloitte Consulting LLP, holding extensive experience across a broad spectrum of issues in the pharmaceutical, biotech and medical device industries and regulatory science. She has held key leadership roles in academia, at federal research and regulatory organizations including the NIH, the Foundation for NIH (FNIH) and the FDA and, most recently, within private industry. Her experiences include developing strategies for R&D, governance, business development, as well as the design, implementation, and management of large-scale scientific programs at the NIH, FNIH, FDA, academia and industry. She has worked across multiple therapeutic and disease prevention areas as well as in medical product development, addressing specific product development issues, regulatory challenges as well as global health needs. Dr. Sanhai has a Ph.D., in clinical biochemistry and an Executive MBA. She holds faculty positions at Duke University, School of Medicine, and the School of Business at University of Maryland.